--- page 1 --- CF PharmTech, Inc. / 長風藥業股份有限公司 ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as those defined in the prospectus dated September 26, 2025 (the “Prospectus”) issued by CF PharmTech, Inc. (長風藥業股份有限公司) (the “Company”). SUMMARY Company information Stock code 2652 Stock short name CF PHARMTECH Dealings commencement date October 8, 2025* *see note at the end of the announcement Price Information Final Offer Price HK$14.75 Offer Shares and Share Capital Number of Offer Shares 41,198,000 H Shares Final Number of Offer Shares in Hong Kong Public Offering 4,120,000 H Shares Final Number of Offer Shares in International Offering 37,078,000 H Shares Number of issued Shares upon Listing 411,978,387 Shares Proceeds Gross proceeds (Note) HK$ 607.7 million Less: Estimated listing expenses payable based on Offer Price HK$(82.3) million Net proceeds HK$ 525.4 million Note: Gross proceeds refers to the amount to which the Company is entitled receive. For details of the use of proceeds, please refer to the section headed “Future Plans and Use of Proceeds” of the Prospectus dated September 26, 2025. ALLOTMENT RESULTS DETAILS HONG KONG PUBLIC OFFERING No. of valid applications 264,209 No. of successful applications 8,240 Subscription level 6,697.80 times Claw-back triggered N/A No. of Offer Shares initially available under the Hong Kong Public Offering 4,120,000 H Shares No. of Offer Shares reallocated from the International Offering (claw-back) N/A Final no. of Offer Shares under the Hong Kong Public Offering 4,120,000 H Shares % of Offer Shares under the Hong Kong Public Offering to the Global Offering 10.00% --- page 2 --- Note: For details of the final allocation of shares of the H Shares to the Hong Kong Public Offering, investors can refer to www.eipo.com.hk/eIPOAllotment to perform a search by identification number or www.eipo.com.hk/eIPOAllotment for the full list of allottees. INTERNATIONAL OFFERING No. of placees 70 Subscription Level 12.74 times No. of Offer Shares initially available under the International Offering 37,078,000 H Shares No. of Offer Shares reallocated to the Hong Kong Public Offering (claw-back) N/A Final no. of Offer Shares under the International Offering 37,078,000 H Shares % of Offer Shares under the International Offering to the Global Offering 90.00% The Directors confirm that, to the best of their knowledge, information and belief, save for a consent under paragraph 1C(2) of Appendix F1 to the Listing Rules (the “Placing Guidelines”) and Chapter 4.15 of the Guide for New Listing Applicants granted by the Stock Exchange to permit the Company to, among other things, allocate certain Offer Shares in the International Offering to a close associate of existing Shareholders of the Company , (i) none of the Offer Shares subscribed by the placees and the public have been financed directly or indirectly by the Company, any of the Directors, Supervisors, chief executive of the Company, Single Largest Group of Shareholders, substantial Shareholders, existing Shareholders of the Company or any of its subsidiaries or their respective close associates; and (ii) none of the placees and the public who have purchased the Offer Shares are accustomed to taking instructions from the Company, any of the Di rectors, Supervisors, chief executive of the Company, Single Largest Group of Shareholders, substantial Shareholders, existing Shareholders of the Company or any of its subsidiaries or their respective close associates in relation to the acquisition, disposal, voting or other disposition of H Shares registered in his/her/its name or otherwise held by him/her/it. ALLOTEES WITH WAIVERS/CONSENTS OBTAINED Investor No. of Offer Shares allocated % of Offer Shares % of total issued H Shares after the Global Offering % of total issued share capital after the Global Offering Relationship Allotee with consent under paragraph 1C(2) of the Placing Guidelines and Chapter 4.15 of the Guide for New Listing Applicants in relation to subscription for Offer Shares by a close associate of existing Shareholders Huang Hongbin (黃宏彬 ) ( “Mr. Huang”) 813,500 1.97% 0.27% 0.20% A close associate of existing Shareholders Allotees with consent under paragraph 1C( 1) of the Placing Guidelines and Chapter 4.15 of the Guide for New Listing Applicants in relation to allocations to connected clients Note CITIC Securities International Capital Management 5,000 0.0121% 0.0017% 0.0012% A Connected Client --- page 3 --- Investor No. of Offer Shares allocated % of Offer Shares % of total issued H Shares after the Global Offering % of total issued share capital after the Global Offering Relationship Limited (“CSICM”) China Asset Management (Hong Kong) Limited (“China AMC HK”) 5,000 0.0121% 0.0017% 0.0012% A Connected Client CMBI (Singapore) Pte. Limited (“CMBI SG”) 10,500 0.0255% 0.0035% 0.0025% A Connected Client Bosera Asset Management (International) Co., Ltd (“Bosera AM”) 10,500 0.0255% 0.0035% 0.0025% A Connected Client Note: For details of the consent under paragraph 1C(1) of the Placing Guidelines and Chapter 4.15 of the Guide for New Listing Applicants in relation to allocations to connected clients, please refer to the section headed “Others/Additional Information – Placing to Connected Clients with a Prior Consent under Paragraph 1C(1) of the Placing Guidelines” in this announcement. LOCK-UP UNDERTAKINGS Single Largest Group of Shareholders Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note Suzhou Pyramid Investment Management Enterprise (Limited Partnership) / 蘇 州嶺頭投資管 理企業(有限合 夥) 10,451,618 15,677,427 5.2% 6.3% October 7, 2026 Suzhou Meizhongrui 9,585,819 14,378,728 4.8% 5.8% October 7, 2026 --- page 4 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note Investment Management Enterprise (Limited Partnership) / 蘇 州美中瑞投資 管理企業(有限 合夥) Suzhou Minmei Investment Management Enterprise (Limited Partnership) / 蘇 州閩美投資管 理企業(有限合 夥) 8,425,531 12,638,297 4.2% 5.1% October 7, 2026 Suzhou Yuanchen Enterprise Management Center (Limited Partnership) / 蘇 州遠辰企業管 理中心(有限合 夥) 7,731,913 11,597,869 3.8% 4.7% October 7, 2026 Suzhou Wolun Enterprise Management Center (Limited Partnership) / 蘇 州沃倫企業管 理中心(有限合 夥) 4,225,542 6,338,312 2.1% 2.6% October 7, 2026 Subtotal 40,420,423 60,630,633 20.1% 24.5% Note: The expiry date of the lock -up period shown in the table above is pursuant to the PRC Company Laws. In accordance with the relevant Listing Rules/guidance materials, the required lock -up for existing Shareholders ends on October 7, 2026, being 12 months following the Listing Date. --- page 5 --- Pre-IPO Investors Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Future Industry Investment Fund (Limited Partnership) / 先 進 製 造 產 業 投 資基金(有限合 夥) – 26,058,641 8.6% 6.3% October 7, 2026 China- Singapore Suzhou Industrial Park Venture Co., Ltd. / 中新蘇州 工 業 園 區 創 業 投 資 有 限 公 司 Note 1 – 12,797,494 4.2% 3.1% October 7, 2026 Jiangsu Jiequan Oriza Intellectual Property Science and Technology Innovation Fund (Limited Partnership) / 江 蘇 疌 泉 元 禾 知 識 產 權 科 創 基 金( 有限合夥 ) Note 1 – 3,614,664 1.2% 0.9% October 7, 2026 Shanghai Sihong Investment Partnership (Limited Partnership) / 上 海 思 宏 投 資 合 夥企業(有限合 夥 ) (currently known as Shanghai Sihongda Enterprise 15,165,653 – – 3.7% October 7, 2026 --- page 6 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Management Consulting Partnership (Limited Partnership) ( 上 海 思 宏 達 企 業 管 理 諮 詢 合 夥 企業 ( 有 限 合 夥))) Beijing SL Pharmaceutical Co., Ltd. / 北京 雙 鷺 藥 業 股 份 有限公司 10,615,653 4,550,000 1.5% 3.7% October 7, 2026 Jiangsu CMB Modern Industry Equity Investment Fund Phase I (Limited Partnership) / 江 蘇 招 銀 現 代 產 業 股 權 投 資 基 金一期(有限合 夥) Note 2 13,545,187 – – 3.3% October 7, 2026 Nanjing CMB Gongying Equity Investment Partnership Enterprise (Limited Partnership) / 南 京 市 招 銀 共 贏 股 權 投 資 合 夥 企業 ( 有 限 合 夥) Note 2 120,490 – – 0.0%* October 7, 2026 Shanghai Lianyi Investment Center (Limited Partnership) / 上 海 聯 一 投 資 中 心(有限合夥) – 12,048,878 4.0% 2.9% October 7, 2026 --- page 7 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Shenzhen GTJA Ruipeng Investment Partnership (Limited Partnership) / 深 圳 市 高 特 佳 睿 鵬 投 資 合 夥 企 業( 有限合夥 ) Note 3 – 6,024,439 2.0% 1.5% October 7, 2026 Jiangsu Jiequan GTJA Medical Industry Investment Fund (Limited Partnership) / 江 蘇 疌 泉 高 特 佳 醫 療 產 業 投 資 基金 ( 有 限 合 夥) Note 3 – 5,470,464 1.8% 1.3% October 7, 2026 CICC Generation (Suzhou) Emerging Industry Equity Investment Fund Partnership (Limited Partnership) / 中 金啟辰 ( 蘇州 ) 新 興 產 業 股 權 投資 基金合夥 企業 ( 有 限 合 夥) 3,401,474 7,936,774 2.6% 2.8% October 7, 2026 Suzhou Meimin Enterprise Management Center (Limited Partnership) / 蘇 州 美 閩 企 業 管 理中心(有限合 夥) 4,316,560 6,474,841 2.1% 2.6% October 7, 2026 --- page 8 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Shanghai Jinshahe Equity Investment Enterprise (Limited Partnership) / 上 海 金 沙 河 股 權 投資企業(有限 合夥) (currently known as Shanghai Jinshahe Venture Capital Partnership (Limited Partnership) (上 海 金 沙 河 創 業 投 資 合 夥 企 業 (有限合夥))) – 9,851,194 3.3% 2.4% October 7, 2026 Zhuhai Longmen Changfeng Investment Partnership (Limited Partnership) / 珠 海 隆 門 長 風 投 資合夥企業(有 限合夥) 4,602,810 4,602,810 1.5% 2.2% October 7, 2026 CICC Qide (Xiamen) Innovation Biomedical Equity Investment Fund Partnership (Limited Partnership) / 中 金啟德 ( 廈門 ) 創 新 生 物 醫 藥 股 權 投 資 基 金 合夥企業 (有限 2,690,741 6,278,395 2.1% 2.2% October 7, 2026 --- page 9 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 合夥) (currently known as CICC Biomedical Fund L.P. (中金 啟德 ( 廈門 ) 創 新 生 物 醫 藥 創 業 投 資 合 夥 企 業(有限合夥))) Shenzhen Qianhai Yuanming Medical Industry Investment Fund (Limited Partnership) / 深 圳 前 海 元 明 醫 療 產 業 投 資 基 金(有限合夥) – 8,677,133 2.9% 2.1% October 7, 2026 Unique Classic Limited – 8,434,214 2.8% 2.0% October 7, 2026 Suzhou Longmen No. 1 Pharmaceutical Investment Partnership (Limited Partnership) / 蘇 州 隆 門 一 號 醫 藥 投 資 合 夥 企 業( 有限合夥 ) Note 4 – 6,024,439 2.0% 1.5% October 7, 2026 Suzhou Longmen Yusen Venture Capital Partnership (Limited Partnership) / 蘇 州 隆 門 玉 森 創 業 投 資 合 夥 企 業( 有限合夥 ) Note 4 – 1,600,001 0.5% 0.4% October 7, 2026 --- page 10 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 CCB International Industrial Fund Management (Hengqin) Co., Ltd. / 建銀國際 產 業 基 金 管 理 ( 橫琴 ) 有限公 司 – 7,364,496 2.4% 1.8% October 7, 2026 Yantai Duoying New Kinetic Energy Investment Center (Limited Partnership) / 煙 台 多 盈 新 動 能 投資中心(有限 合夥) Note 5 1,814,664 1,800,000 0.6% 0.9% October 7, 2026 Qingdao Finnova Energy Conservation and Environmental Protection Venture Investment Fund Partnership (Limited Partnership) / 青 島 源 創 節 能 環 保 創 業 投 資 基 金合夥企業(有 限合夥) Note 5 2,314,664 1,300,000 0.4% 0.9% October 7, 2026 Shanghai Hanren Equity Investment Center (Limited Partnership) / 上 海 漢 仁 股 權 投 資中心(有限合 夥) – 7,164,180 2.4% 1.7% October 7, 2026 --- page 11 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Changzhou Feijun Longcheng Equity Investment Partnership (Limited Partnership) / 常 州 斐 君 隆 成 股 權 投 資 合 夥 企 業( 有限合夥 ) Note 6 – 2,904,067 0.1% 0.7% October 7, 2026 Ningbo Feijun Yuanchuan Equity Investment Partnership (Limited Partnership) / 寧 波 斐 君 元 川 股 權 投 資 合 夥 企 業( 有限合夥 ) Note 6 – 1,566,350 0.5% 3.7% October 7, 2026 Guangzhou Huangpu Yongping Science and Technology Equity Investment Partnership (Limited Partnership) / 廣 州 黃 埔 永 平 科 創股權 投資合 夥企業(有限合 夥) Note 6 – 1,106,582 0.4% 0.3% October 7, 2026 Changzhou Feijun Yongjun Equity Investment Partnership (Limited – 1,106,582 0.4% 0.3% October 7, 2026 --- page 12 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Partnership) / 常 州 斐 君 永 君 股 權 投 資 合 夥 企 業(有限合夥)) Note 6 Anhui Xin’an Cornerstone Industry Upgrade Fund Partnership (Limited Partnership) / 安 徽 信 安 基 石 產 業 升 級 基 金 合 夥企業(有限合 夥) 6,024,439 – – 1.5% October 7, 2026 Shanghai Jinpu Guotiao Merger Equity Investment Fund Partnership (Limited Partnership) / 上 海 金 浦 國 調 併 購 股 權 投 資 基 金合夥企業 (有限合夥) – 5,532,910 1.8% 1.3% October 7, 2026 Shanghai Jianli Investment Partnership (Limited Partnership) / 上 海 簡 理 投 資 合 夥企業(有限合 夥) – 3,682,248 1.2% 0.9% October 7, 2026 Suzhou Mengxi Venture Investment Center (Limited Partnership) / 蘇 州 孟 溪 創 業 投 – 3,614,664 1.2% 0.9% October 7, 2026 --- page 13 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 資中心(有限合 夥) Tianjin Yuanyi Kaiyuan Asset Management Center (Limited Partnership) / 天 津 遠 翼 開 元 資 產管理中心(有 限合夥) – 3,614,657 1.2% 0.9% October 7, 2026 Langma No. 18 (Shenzhen) Venture Capital Center (Limited Partnership) / 朗 瑪十八號 ( 深 圳)創業投資中 心( 有限合夥 ) Note 7 – 2,289,283 0.8% 0.6% October 7, 2026 Langma No. 17 (Shenzhen) Venture Capital Center (Limited Partnership) / 朗 瑪十七號 ( 深 圳)創業投資中 心( 有限合夥 ) Note 7 – 1,325,374 0.4% 0.3% October 7, 2026 Chengdu Boyuan Jiayu Venture Capital Partnership (Limited Partnership) / 成 都 博 遠 嘉 昱 創 業 投資合夥企 業(有限合夥) – 3,319,747 1.1% 0.8% October 7, 2026 Shanghai Yangtze River Delta Industry Upgrade Equity Investment – 3,319,747 1.1% 0.8% October 7, 2026 --- page 14 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Partnership (Limited Partnership) / 上 海 長 三 角 產 業 升 級 股 權 投 資 合夥企業(有限 合夥) Changzhou Feijun Equity Investment Partnership (Limited Partnership) / 常 州 斐 君 股 權 投 資合夥企業 (有限合夥) Note 8 – 2,409,773 0.8% 0.6% October 7, 2026 Guangzhou Huangpu Feijun Industry Investment Fund Partnership (Limited Partnership) / 廣 州 黃 埔 斐 君 產 業 投 資 基 金 合 夥企業(有限合 夥) Note 8 – 843,420 0.3% 0.2% October 7, 2026 Shenzhen Qianhai Kangda Science and Technology Venture Investment Partnership (Limited Partnership) / 深 圳 前 海 康 達 科 技 創 業 投 資 合 夥企業(有限合 夥) – 2,379,151 0.8% 0.6% October 7, 2026 --- page 15 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Pingtan Comprehensive Experimental Zone Watson Huijia Equity Investment Partnership (Limited Partnership) / 平 潭 綜 合 實 驗 區 沃 生 慧 嘉 股 權 投 資 合 夥 企 業 (有限合夥) – 2,213,165 0.7% 0.5% October 7, 2026 Wuhu Taichu Investment Partnership (Limited Partnership / 蕪 湖 太 初 投 資 合 夥企業(有限合 夥) 1,106,582 1,106,583 0.4% 0.5% October 7, 2026 Yangzhou Tenglan Equity Investment Partnership (Limited Partnership) / 揚 州 騰 嵐 股 權 投 資合夥企業 (有限合夥) Note 9 – 1,770,532 0.6% 0.4% October 7, 2026 Changzhou Tengren Equity Investment Partnership (Limited Partnership) / 常 州 騰 壬 股 權 投 資合夥企業(有 限合夥) Note 9 – 442,633 0.1% 0.1% October 7, 2026 Wuxi Lejin Fengyun 1,841,124 – – 0.4% October 7, 2026 --- page 16 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Investment Enterprise (Limited Partnership) / 無 錫 樂 金 風 雲 投 資企業(有限合 夥) Ningbo Meishan Free Trade Port Xinfei Dingke Investment Management Partnership (Limited Partnership) / 寧 波 梅 山 保 稅 港 區 新 菲 鼎 柯 投 資 管 理 合 夥 企 業( 有限合夥 ) Note 10 – 1,196,731 0.4% 0.3% October 7, 2026 Xinyu Xinding Kenge No. 12 Investment Management Partnership (Limited Partnership) (新 余 新 鼎 啃 哥 拾 貳 號 投 資 管 理 合夥企業 (有 限合夥)) Note 10 – 552,338 0.2% 0.1% October 7, 2026 Suzhou Yueliang Enterprise Management Partnership (Limited Partnership) (蘇 州 閱 良 企 業 管 理合夥企業(有 限合夥 )) (formerly known – 1,483,445 0.5% 0.4% October 7, 2026 --- page 17 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 as Shanghai Yueliang Enterprise Management Partnership (Limited Partnership) (上 海 閱 良 企 業 管 理合夥企業(有 限合夥))) Suzhou Shengyuan Enterprise Management Center (Limited Partnership) ( 蘇 州 晟 源 企 業 管 理中心(有限合 夥)) 575,423 863,135 0.3% 0.3% October 7, 2026 Ms. CHEN Xiangyun 804,884 400,000 0.1% 0.3% October 7, 2026 Guangzhou Xinxing Venture Capital Partnership (Limited Partnership) (廣州新星創業 投 資 合 夥 企 業 ( 有 限 合 夥 )) (currently known as Guangzhou Xinxing Huacheng Venture Capital Partnership (Limited Partnership) (廣 州 新 星 花 城 創 業 投 資 合 夥 企 業(有限合夥))) – 1,106,582 0.4% 0.3% October 7, 2026 --- page 18 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 Guangzhou Zhiyuan Xinxing Equity Investment Partnership (Limited Partnership) ( 廣 州 致 遠 新 星 股 權 投 資 合 夥 企 業(有限合夥)) – 1,106,582 0.4% 0.3% October 7, 2026 Suzhou Wosheng Enterprise Management Center (Limited Partnership) ( 蘇 州 沃 昇 企 業 管 理中心(有限合 夥)) – 644,393 0.2% 0.2% October 7, 2026 Shenzhen CMB Gongying Equity Investment Partnership Enterprise (Limited Partnership) ( 深 圳 市 招 銀 共 贏 股 權 投 資 合 夥 企業 ( 有 限 合 夥)) 394,030 – – 0.1% October 7, 2026 Mr. MI Jinyong – 210,612 0.1% 0.1% October 7, 2026 Mr. GENG Shaofeng – 210,610 0.1% 0.1% October 7, 2026 Subtotal 69,334,378 200,394,953 66.3% 65.5% * denotes less than 0.05% Notes: 1. Each an investment arm of Oriza Funds. 2. Each an investment arm of CMB Funds. --- page 19 --- Name Number of Unlisted Shares held in the Company subject to lock- up undertakings upon Listing Number of H Shares held in the Company subject to lock- up undertakings upon Listing % of total issued H Shares after the Global Offering subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing Last day subject to the lock-up undertakings Note 11 3. Each an investment arm of GTJA Investment Group. 4. Each an investment arm of Suzhou Longmen Venture Capital. 5. Each an investment arm of Finnova Funds. 6. Each an investment arm of Mild Investment. 7. Each an investment arm of Everest Ventures. 8. Each an investment arm of Feijun Investment. 9. Each an investment arm of Tengwu Investment. 10. Each an investment arm of Xinding Capital. 11. The expiry date of the lock-up period shown in the table above is pursuant to the PRC Company Laws. In accordance with the relevant Listing Rules/guidance materials, the required lock-up for existing Shareholders ends on October 7, 2026, being 12 months following the Listing Date. --- page 20 --- PLACEE CONCENTRATION ANALYSIS Placees Number of H Shares allotted Allotment as % of International Offering Allotment as % of total Offer Shares Number of Shares held upon Listing % of total issued share capital upon Listing Top 1 12,130,500 32.72% 29.44% 12,130,500 2.94% Top 5 29,927,500 80.71% 72.64% 29,927,500 7.26% Top 10 33,358,000 89.97% 80.97% 36,611,193 8.89% Top 25 36,169,000 97.55% 87.79% 39,422,193 9.57% Note: * Ranking of placees is based on the number of H Shares allotted to the placees. H SHAREHOLDERS CONCENTRATION ANALYSIS H Shareholders* Number of H Shares allotted Allotment as % of International Offering Allotment as % of total Offer Shares Number of H Shares held upon Listing % of total issued H Shares capital upon Listing Number of Shares held upon Listing Top 1 0 0.00% 0.00% 60,630,633 20.06% 101,051,056 Top 5 12,130,500 32.72% 29.44% 134,230,700 44.41% 174,651,123 Top 10 22,977,500 61.97% 55.77% 185,732,828 61.46% 226,153,251 Top 25 23,791,000 64.16% 57.75% 266,030,094 88.02% 332,077,755 Note: * Ranking of H Shareholders is based on the number of H Shares held by the H Shareholders upon Listing. SHAREHOLDER CONCENTRATION ANALYSIS Shareholders Number of H Shares allotted Allotment as % of International Offering Allotment as % of total Offer Shares Number of H Shares held upon Listing Number of Shares held upon Listing % of total issued share capital upon Listing Top 1 0 0.00% 0.00% 60,630,633 101,051,056 24.53% Top 5 0 0.00% 0.00% 126,650,200 177,686,276 43.13% Top 10 12,130,500 32.72% 29.44% 162,324,481 242,191,887 58.79% Top 25 23,791,000 64.16% 57.75% 255,261,286 360,294,044 87.45% Note: --- page 21 --- * Ranking of Shareholders is based on the number of Shares (of all classes) held by the Shareholder s upon Listing. BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING Subject to the satisfaction of the conditions set out in the Prospectus, valid applications made by the public will be conditionally allocated on the basis set out below: NO. OF H SHARES APPLIED FOR NO. OF VALID APPLICATIONS BASIS OF ALLOTMENT/BALLOT APPROXIMATE PERCENTAGE OF ALLOTTED SHARES OF THE TOTAL NO. OF SHARES APPLIED FOR POOL A 500 83,975 840 out of 83,975 to receive 500 Shares 1.00% 1,000 19,181 193 out of 19,181 to receive 500 Shares 0.50% 1,500 9,535 97 out of 9,535 to receive 500 Shares 0.34% 2,000 7,889 82 out of 7,889 to receive 500 Shares 0.26% 2,500 6,257 66 out of 6,257 to receive 500 Shares 0.21% 3,000 8,435 91 out of 8,435 to receive 500 Shares 0.18% 3,500 2,718 30 out of 2,718 to receive 500 Shares 0.16% 4,000 2,956 33 out of 2,956 to receive 500 Shares 0.14% 4,500 2,051 24 out of 2,051 to receive 500 Shares 0.13% 5,000 9,073 109 out of 9,073 to receive 500 Shares 0.12% 6,000 4,702 57 out of 4,702 to receive 500 Shares 0.10% 7,000 3,636 45 out of 3,636 to receive 500 Shares 0.09% 8,000 2,535 32 out of 2,535 to receive 500 Shares 0.08% 9,000 2,102 28 out of 2,102 to receive 500 Shares 0.07% 10,000 9,251 128 out of 9,251 to receive 500 Shares 0.07% 15,000 5,904 114 out of 5,904 to receive 500 Shares 0.06% 20,000 4,843 110 out of 4,843 to receive 500 Shares 0.06% 25,000 3,822 87 out of 3,822 to receive 500 Shares 0.05% 30,000 3,701 100 out of 3,701 to receive 500 Shares 0.05% 35,000 2,778 78 out of 2,778 to receive 500 Shares 0.04% 40,000 2,463 71 out of 2,463 to receive 500 Shares 0.04% 45,000 1,957 58 out of 1,957 to receive 500 Shares 0.03% 50,000 4,353 130 out of 4,353 to receive 500 Shares 0.03% 60,000 3,165 95 out of 3,165 to receive 500 Shares 0.03% 70,000 2,635 82 out of 2,635 to receive 500 Shares 0.02% 80,000 1,989 62 out of 1,989 to receive 500 Shares 0.02% 90,000 1,733 55 out of 1,733 to receive 500 Shares 0.02% 100,000 11,553 368 out of 11,553 to receive 500 Shares 0.02% 200,000 7,222 295 out of 7,222 to receive 500 Shares 0.01% 300,000 10,501 560 out of 10,501 to receive 500 Shares 0.01% 242,915 Total number of Pool A successful applicants: 4 ,120 POOL B 400,000 5,262 437 out of 5,262 to receive 500 Shares 0.01% 500,000 2,606 270 out of 2,606 to receive 500 Shares 0.01% 600,000 1,881 234 out of 1,881 to receive 500 Shares 0.01% 700,000 1,497 217 out of 1,497 to receive 500 Shares 0.01% 800,000 1,162 193 out of 1,162 to receive 500 Shares 0.01% --- page 22 --- NO. OF H SHARES APPLIED FOR NO. OF VALID APPLICATIONS BASIS OF ALLOTMENT/BALLOT APPROXIMATE PERCENTAGE OF ALLOTTED SHARES OF THE TOTAL NO. OF SHARES APPLIED FOR 900,000 842 157 out of 842 to receive 500 Shares 0.01% 1,000,000 2,874 596 out of 2,874 to receive 500 Shares 0.01% 1,500,000 1,656 515 out of 1,656 to receive 500 Shares 0.01% 2,060,000 3,514 1,501 out of 3,514 to receive 500 Shares 0.01% 21,294 Total number of Pool B successful applicants: 4,120 As of the date of this announcement, the relevant subscription monies previously deposited in the designated nominee accounts have been remitted back to the accounts of all HKSCC participants. Investors should contact their relevant brokers for any inquiries. COMPLIANCE WITH LISTING RULES AND GUIDANCE The Directors confirm that, except for the Listing Rules that have been waived and/or in respect of which consent has been obtained, the Company has complied with the Listing Rules and guidance materials in relation to the placing, allotment and listing of the Company’s H Shares. The Directors confirm that, to the best of their knowledge, the consideration payable by the placees or the public (as the case maybe) directly or indirectly for each Offer Share subscribed for or purchased by them was the same as the Offer Price in addition to any brokerage, AFRC transaction levy, SFC transaction levy and trading fee payable. OTHERS/ADDITIONAL INFORMATION Placing to a close associate of existing Shareholders with prior consent under paragraph 1C(2) of Appendix F1 to the Listing Rules (the Placing Guidelines) Mr. Huang The Company has applied to the Stock Exchange for, and the Stock Exchange has granted, a consent under paragraph 1C(2) of the Placing Guidelines to permit the Company to allocate such Offer Shares in the International Offering to Mr. Huang. Mr. Huang is a close associate of Changzhou Feijun Equity Investment Partnership (Limited Partnership) ( 常州斐君股權投資合夥企業(有限合夥)) and Guangzhou Huangpu Feijun Industry Investment Fund Partnership (Limited Partnership) ( 廣州黃埔斐君產業投資基金合夥企業(有限 合夥)), both of which are existing Shareholders of the Company. The allocation of the Offer Shares to Mr. Huang is in compliance with all the conditions under the consent granted by the Stock Exchange, including but not limited to that no preferential treatment was given to Mr. Huang in the allocation process by virtue of his relationship with the Company. --- page 23 --- For details of the allocations of Offer Shares to Mr. Huang, please refer to the section headed “Allotment Results Details – International Offering – Allotees with Waivers/Cons ents Obtained” in this announcement. Placing to connected clients with a prior consent under paragraph 1C(1) of Appendix F1 to the Listing Rules (the Placing Guidelines) The Company has applied to the Stock Exchange for, and the Stock Exchange has granted, a consent under paragraph 1C(1) of the Placing Guidelines to permit the Company to allocate such Offer Shares in the International Offering to CSICM, China AMC HK, CMBI SG and Bosera AM, each of which is a connected client of certain distributors. Please also refer to the section below headed “Placing to connected clients with a prior consent under paragraph 1C(1) of the Placing Guidelines” for details. Under the International Offering, certain Offer Shares were placed to certain connected clients of their connected distributors pursuant to the Placing Guidelines. Please refer to the section headed “Allotment Results Details – International Offering – Allotees with Waivers/Consents Obtained” in this announcement for details. The Co mpany has applied to the Stock Exchange for, and the Stock Exchange has granted, a consent under paragraph 1C(1) of the Placing Guidelines to permit the Company to allocate such Offer Shares in the International Offering to certain connected clients. The allocation of Offer Shares to such connected clients is in compliance with all the conditions under the consent granted by the Stock Exchange. Details of the placement to connected clients are set out below. No. Connected Client Connected Distributor Relationship with the Connected Distributor Whether the connected client will hold beneficial interests of Offer Shares on a nondiscretionary or discretionary basis for independent third parties Number of Offer Shares to be allocated to the connected client Appropriate percentage of total number of Offer Shares Approximate percentage of total issued share capital immediately following the completion of Global Offering 1. CSICM (Note 1) CLSA Limited (“CLSA”) CSICM is a member of the same group of CLSA. Non- discretionary basis 5,000 0.0121% 0.0012% 2. China AMC HK (Note 2) CLSA China AMC HK is a member of the same group of CLSA. Discretionary basis 5,000 0.0121% 0.0012% 3. CMBI SG (Note 3) CMB International Capital Limited (“CMBI”), CMB International Securities Limited (“CMBI Securities”) CMBI SG is a member of the same group with CMBI, CMBI Securities and CMBI Global Markets. Discretionary basis 10,500 0.0255% 0.0025% --- page 24 --- No. Connected Client Connected Distributor Relationship with the Connected Distributor Whether the connected client will hold beneficial interests of Offer Shares on a nondiscretionary or discretionary basis for independent third parties Number of Offer Shares to be allocated to the connected client Appropriate percentage of total number of Offer Shares Approximate percentage of total issued share capital immediately following the completion of Global Offering and CMB International Global Markets Limited (“CMBI Global Markets”, together with CMBI and CMBI Securities, the “CMBI Connected Distributors”) 4. Bosera AM (Note 4) CMBI Connected Distributors Bosera AM is a member of the same group with CMBI, CMBI Securities and CMBI Global Markets. Discretionary basis 10,500 0.0255% 0.0025% Notes: 1. PRC investors are currently not permitted under applicable PRC laws to participate directly in initial public offerings (“IPOs”) in Hong Kong. However, PRC investors are permitted to invest in products issued by appropriate domestic securities firms licensed to undertake cross -border derivatives trading activities. In connection with such products, the licensed do mestic securities firms, through their Hong Kong affiliates, may participate in Hong Kong IPOs either as placees or cornerstone investors (the “ Cross-border Derivatives Trading Regime”). CITIC Securities Company Limited (“ CITIC Securities ”), the shares of which are listed on both the Shanghai Stock Exchange (stock code: 600030) and the Stock Exchange (stock code: 6030), is one of the domestic securities firms licensed to undertake cross-border derivatives trading activities. CITIC Securities entered into an International Swaps and Derivatives Association agreement (the “ISDA Agreement”) with its indirectly wholly-owned subsidiary, CSICM to set out the principal terms of any future total return swap between CITIC Securities and CSICM. CLSA is an Overall Coordinator, Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager in connection with the Global Offering. Pursuant to the ISDA Agreement, CSICM, which intends to participate in the Global Offering as a placee, will hold the Offer Shares on a non-discretionary basis as the single underlying holder under a back -to-back total return swap (the “ Back-to-back TRS ”) to be entered by CSICM with CITIC Securities in connection with a Client TRS (as defined below) placed by and fully funded (i.e. with no financing provided by CSICM) by the CSICM Ultimate Client (as defined below), pursuant to which CSICM will pass the full economic exposure of the Offer Shares to the CSICM Ultimate Client, which in effect, CSICM will hold the beneficial interest of the Offer Shares on behalf of the CSICM Ultimate Client. CSICM is indirectly wholly owned by CITIC Securities. CLSA is also indirectly wholly owned by CITIC --- page 25 --- No. Connected Client Connected Distributor Relationship with the Connected Distributor Whether the connected client will hold beneficial interests of Offer Shares on a nondiscretionary or discretionary basis for independent third parties Number of Offer Shares to be allocated to the connected client Appropriate percentage of total number of Offer Shares Approximate percentage of total issued share capital immediately following the completion of Global Offering Securities. Therefore, CSICM is a member of the same group of companies as CLSA. Accordingly, CSICM is considered as a “connected client” of CLSA pursuant to paragraph 1B(7) of the Placing Guidelines. Pursuant to the Cross -border Derivatives Trading Regime, the onshore investor (the “CSICM Ultimate Client”) cannot directly subscribe for the Offer Shares but may invest in derivative products issued by domestic securities firms licenced to undertake cross -border derivatives trading activities, such as CITIC Securities, with the Offer Shares as the underlying assets. Instead of directly subscribing for the Offer Shares, the CSICM Ultimate Client will subscribe for the Offer Shares, the CSICM Ultimate Client will place a total return swap order (the “Client TRS”) with CITIC Securities in connection with the Company’s IPO and CITIC Securities will place a Back -to-back TRS order to CSICM on the terms of the ISDA Agreement. In order to hedge its exposure under the Back -to-back TRS, CSICM participates in the Company’s IPO and subscribes the Offer Shares through placing order with CLSA during the International Offering. The CSICM Ultimate Client for purpose of this placing subscription include the following investment fund managed by Shanghai Panjing Investment Management Center (Limited Partnership) (上海盘京投资管理 中心（有限合伙）): (a) Shanghai Panjing Investment Management Center (Limited Partnership) (上海盘京投资管理中心 （有限合伙）), whose ultimate beneficial owner holding 30% interests or more therein is Zhuang Tao (庄涛). To the best knowledge of CSICM after making all reasonable enquiries, the CSICM Ultimate Client is an independent third party of CSICM and CLSA, the companies which are members of the same group of companies as CLSA and the Company. Pursuant to the terms of the contracts of the Back -to-back TRS and the Client TRS, during the tenor of the Back-to-back TRS and the Client TRS, all economic returns of the Offer Shares will be passed to the CSICM Ultimate Client through the Back-to-back TRS and the Client TRS and all economic loss shall be borne by the CSICM Ultimate Client. CSICM will not take any economic return or bear any economic loss in relation to the Offer Shares. Investment in the Back-to-back TRS and the Client TRS is similar to the investment in a qualified domestic institutional investor fund (“QDII”) in the way that the CSICM Ultimate Client would reap all the economic benefits of the underlying Offer Shares, except that a QDII fund would pass through the exchange rate exposure on both the notional value of the investment and the profit and loss of the investment. In contrast, the profit and loss of the Back-to-back TRS and the Client TRS factor into account the fluctuation in RMB exchange rate upon termination of the Client TRS by converting the profit and loss using the current exchange rate at the time of termination. As such, the CSICM Ultimate Client would bear the exchange rate exposure of the profit and loss on settlement date. The CSICM Ultimate Client may exercise an early termination right to terminate the Client TRS at any time from the issue date of the Client TRS which should be on or after t he date on which the Offer Shares are listed on the Stock Exchange. Upon the termination upon maturity or early termination of the Client TRS by the CSICM Ultimate Client, CSICM will dispose the Offer Shares on the secondary market and the CSICM Ultimate Client will receive a final settlement amount of the Back-to-back TRS which should have taken into account all the economic returns or economic loss in relation to the Offer Shares. If upon the maturity of the Client TRS, the CSICM Ultimate Client intends to extend the investment period, subject to --- page 26 --- No. Connected Client Connected Distributor Relationship with the Connected Distributor Whether the connected client will hold beneficial interests of Offer Shares on a nondiscretionary or discretionary basis for independent third parties Number of Offer Shares to be allocated to the connected client Appropriate percentage of total number of Offer Shares Approximate percentage of total issued share capital immediately following the completion of Global Offering further agreement between CSICM and the CSICM Ultimate Client, the term of the Client TRS could be extended by way of a new issuance or a tenor extension. Accordingly, CSICM will extend the term of the Back-to-back TRS by way of a new issuance or a tenor extension. It is proposed that CSICM will hold the legal title and the voting right of the Offer Shares by itself, and pass through the economic exposure to the CSICM Ultimate Client, which places a Client TRS order through its asset manager with CITIC Securities in connection with the IPO of the Company. Due to its internal policy, CSICM will not exercise the voting right of the Offer Shares during the tenor of the Back-to-back TRS. During the life of the Client TRS and Back -to-back TRS, CSICM may continue to hold the Offer Shares in its custodian account, or to hold some or all of the Offer Shares in a prime brokerage a ccount for stock borrowing purposes. As permitted under the contractual arrangement with the CSICM Ultimate Client, CSICM will lend out its holding of underlying Offer Shares in the form of stock borrowing loans consistent with market practice to lower its finance costs, provided that CSICM has the ability to call back the Offer Shares on loan at any time in order to satisfy its obligations under the Back -to-back TRS to ensure the economic interests to be passed to the CSICM Ultimate Client under the Client TRS will remain unchanged. 2. China AMC HK will hold the Offer Shares in its capacity as discretionary fund manager managing assets on behalf of its underlying clients. To the best of China AMC HK’s knowledge after due enquiry, each underlying clients of China AMC HK is an independent third party of China AMC HK, CLSA and the companies which are members of the same group of CLSA. 3. CMBI SG will hold the Offer Shares in its capacity as discretionary investment manager managing assets on behalf of its underlyi ng client. To the best of CMBI SG’s knowledge after due enquiry, the underlying client of CMBI SG is an independent third party of CMBI SG, the CMBI Connected Distributors and the companies which are members of the same group of the CMBI Connected Distributors. 4. Bosera AM will hold the Offer Shares in its capacity as discretionary fund manager managing assets on behalf of its underlying clients. To the best of Bosera AM’s knowledge after due enquiry, each underlying clients of Bosera AM is an independent third party of Bosera AM, the CMBI Connected Distributors and the companies which are members of the same group of the CMBI Connected Distributors. DISCLAIMERS Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock Exchange ”) and Hong Kong Securities Clearing Company Limited (“HKSCC”) take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This announcement is not for release, publication, distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and --- page 27 --- the District of Columbia). This announcement does not const itute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “ U.S. Securities Act ”). The securities may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the U.S. Securities Act and in compliance with any applicable state securities laws, or outside the United States unless in compliance with Regulation S under the U.S. Securities Act. There will be no public offer of securities in the United States. The Offer Shares are being offered and sold solely outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act. This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities. This announcement is not a prospectus. Potential investors should read the Prospectus dated September 26, 2025 issued by CF PharmTech, Inc. for detailed information about the Global Offering described below before deciding whether or not to invest in the Shares thereby being offered . *Potential investors of the Offer Shares should note that the Joint Representatives (for themselves and on behalf of the Hong Kong Underwriters) shall be entitled to terminate their obligations under the Hong Kong Underwriting Agreement with immediate effect upon the occurrence of any of the events set out in the paragraph headed “Underwriting – Underwriting Arrangements and Expenses – Hong Kong Public Offering – Hong Kong Underwriting Agreement – Grounds for Termination ” in the Prospectus at any time prior to 8:00 a.m. (Hong Kong time) on the Listing Date (which is currently expected to be on October 8, 2025). PUBLIC FLOAT AND FREE FLOAT Upon Listing, 230,935,230 H Shares, equivalent to 56.1% of the total number of issued Shares of the Company, will be counted towards the public float. Therefore, the number of H Shares held in public hands is higher than the prescribed percentage of H Shares required to be held in public hands under Rule 19A.13A(1) of the Listing Rules, representing 24.7% of H Shares to be held in public hands with the expected market value of HK$1.5 billion at the time of Listing, based on the Offer Price of HK$14.75 per H Share. Based on the Offer Price of HK$14.75 per Share, the Company satisfies t he free float requirement under Rule 19A.13C(1) of the Listing Rules. The Directors confirm that, immediately following the completion of the Global Offering, (i) no placee will, individually, be placed more than 10% of the enlarged issued share capital of the Company immediately after the Global Offering; (ii) there will not be any new substantial Shareholder immediately after the Global Offering; (iii) the three largest public shareholders of the Company do not hold more than 50% of the H Shares in public hands at the time of the Listing in compliance with Rules 8.08(3) and 8.24 of the Listing Rules; and (iv) there will be at least 300 Shareholders at the time of the Listing in compliance with Rule 8.08(2) of the Listing Rules. COMMENCEMENT OF DEALINGS The H Share certificates will only become valid evidence of title at 8:00 a.m. on Wednesday, October 8, 2025 (Hong Kong time), provided that the Global Offering has become unconditional and the right of termination described in the section headed “Underwritin g – Underwriting Arrangements and Expenses – Hong Kong Public Offering – Grounds for Termination” in the Prospectus has not been --- page 28 --- exercised. Investors who trade the H Shares on the basis of publicly available allocation details prior to the receipt of H Sha re certificates or prior to the H Share certificates becoming valid evidence of title do so entirely at their own risk. Assuming that the Global Offering becomes unconditional at or before 8:00 a.m. on Wednesday, October 8, 2025 (Hong Kong time), it is expected that dealings in the H Shares on the Stock Exchange will commence at 9:00 a.m. on Wednesday, October 8, 2025 (Hong Kong time). The H Shares will be traded in board lots of 500 H Shares each, and the stock code of the H Shares will be 2652. By order of the Board CF PharmTech, Inc. 長風藥業股份有限公司 Dr. LIANG Bill Wenqing Chairperson, Executive Director and Chief Executive Officer Hong Kong, October 6, 2025 As at the date of this announcement, the board of directors (“ Board”) comprises of Dr. LIANG Bill Wenqing as the chairperson of the Board, executive Director and Chief Executive Officer, Dr. LI LI BOVET, Dr. LI Qi and Ms. ZHU Yuyu as executive Directors, Mr. CHEN Penghui, Mr. CAI Lei and Dr. YI Hua as non -executive Directors, and Dr. JIN Jian, Ms. WANG Lijuan, Mr. WEI Shirong and Mr. IP Wang Hoi as independent non-executive Directors.